Pazoci 200 Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. Pazoci 200 Tablet is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so Pazoci 200 Tablet targets cancerous cells and blocks the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Pazoci 200 Tablet stops the production, spread and growth of cancerous cells in the body.

FAQs

I am a diabetic person, can i take Pazoci 200 Tablet ?

Pazoci 200 Tablet is safe to be taken by a diabetic person. However, take Pazoci 200 Tablet only after asking with a doctor as they may adjust the dosing according to the condition of the patient.

Can a pregnant lady use Pazoci 200 Tablet ?

Pazoci 200 Tablet is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Pazoci 200 Tablet .

When should I stop the treatment with Pazoci 200 Tablet ?

Pazoci 200 Tablet should be stopped in cases where a person faces serious side effect that affects the quality of life. Otherwise, you need to keep taking Pazoci 200 Tablet until your doctor asks you to stop it.

What should i tell my doctor during consultation?

Before your doctor prescribes you Pazoci 200 Tablet , tell them if you have heart problems, high blood pressure, bleeding issues, surgery or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood).

What are the conditions in which use of Pazoci 200 Tablet is restricted?

Pazoci 200 Tablet is restricted to use in persons who are sensitive to any of its constituents or have squamous cell lung cancer or already taking carboplatin and paclitaxel.